-
1دورية أكاديمية
المؤلفون: Kowsigan Magesan, Purna Nangia, Anitha Manoharan, Ranju K Sitaula, Chandrashekara Srikantiah, Jyotirmay Biswas
المصدر: Indian Journal of Ophthalmology, Vol 72, Iss 5, Pp 677-680 (2023)
مصطلحات موضوعية: anterior uveitis, antinuclear antibodies, immunosuppressants, retinal vasculitis, rituximab, systemic lupus erythematosus, Ophthalmology, RE1-994
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Vineeta Shobha, Vijay Rao, Anu Mohan Desai, Ramesh Jois, Chandrashekara Srikantiah, B G Dharmanand, Sharath Kumar, Pradeep Kumar, Chethana Dharmapalaiah, K M Mahendranath, Shiva Prasad, Manisha Daware, Yogesh Singh, Uma Karjigi
المصدر: Indian Journal of Rheumatology, Vol 14, Iss 1, Pp 17-20 (2019)
مصطلحات موضوعية: Autoimmune, biologics, India, Karnataka biologics cohort, Karnataka, rheumatic diseases, Diseases of the musculoskeletal system, RC925-935
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Arungovind, G., Kamalanathan, A. S.Aff1, Padmanabhan, Venkatesh, Manoharan, AnandAff2, Aff4, Aff5, Chandrashekara, Srikantiah, Venkataraman, KrishnanAff1
المصدر: Journal of Proteins and Proteomics: A Journal of the Proteomics Society, India (PSI). 10(3):235-243
-
4
المؤلفون: Vasudha Bhat, Vijay Rao, Vikram Haridas, Vishnu Priya, Chandrashekara Srikantiah, Benzeeta Pinto, Vineeta Shobha, Yogesh Preet Singh, Ramesh Jois, Ramya Janardana
المصدر: Lupus. 29:1397-1403
مصطلحات موضوعية: Adult, medicine.medical_specialty, India, Severity of Illness Index, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Pre-Eclampsia, Rheumatology, Pregnancy, medicine, Humans, Lupus Erythematosus, Systemic, 030212 general & internal medicine, skin and connective tissue diseases, Pregnancy outcomes, 030203 arthritis & rheumatology, Fetus, Systemic lupus erythematosus, Obstetrics, business.industry, Remission Induction, Infant, Newborn, Pregnancy Outcome, medicine.disease, Lupus Nephritis, Abortion, Spontaneous, Pregnancy Complications, Premature Birth, Fetal outcome, Female, business, Hydroxychloroquine
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aed6c501d5e205b1061da7db04b13975
https://doi.org/10.1177/0961203320944503 -
5
المؤلفون: Vijay Rao, Chandrashekara Srikantiah, Yogesh Preet Singh, Pradeep Kumar, Sharath Kumar, Vineeta Shobha, Anu Mohan Desai, BG Dharmanand, Uma Karjigi, Chethana Dharmapalaiah, Shiva Prasad, Manisha Ashwin Daware, Kurugodu Mathada Mahendranath, Ramesh Jois
المصدر: Indian Journal of Rheumatology, Vol 14, Iss 1, Pp 17-20 (2019)
مصطلحات موضوعية: medicine.medical_specialty, lcsh:Diseases of the musculoskeletal system, Spondyloarthropathy, India, Tertiary care, Etanercept, 03 medical and health sciences, 0302 clinical medicine, Immune system, Rheumatology, Karnataka, Internal medicine, medicine, biologics, Karnataka biologics cohort, 030212 general & internal medicine, Adverse effect, 030203 arthritis & rheumatology, Latent tuberculosis, business.industry, medicine.disease, rheumatic diseases, lcsh:RC925-935, business, medicine.drug, Cohort study, Autoimmune
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e945a1f5e98e90284870957bf98d870e
http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=1;spage=17;epage=20;aulast=Shobha -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
المؤلفون: Upadhyaya S; Senior Consultant Rheumatologist, Department of Rheumatology, Indraprastha Apollo Hospitals, New Delhi, Delhi, India., Kumar U; Head, Department of Rheumatology, All India Institute of Medical Sciences (AIIMS), New Delhi, Delhi, India., Chandrashekara S; Medical Director & Consultant Rheumatologist, Department of Clinical Immunology & Rheumatology, ChanRe Rheumatology & Immunology Center & Research, Bengaluru, Karnataka, India., Krishnamurthy V; Consultant Rheumatologist, Department of Rheumatology, Chennai Meenakshi Multispecialty Hospital, Chennai, Tamil Nadu, India., Bandyopadhyay S; Senior Consultant Physician, Department of Internal Medicines and Rheumatology, Apollo Gleneagles Hospital, Kolkata, West Bengal, India., Surin A; Senior Consultant Rheumatologist, Department of Rheumatology, Apollo Hospital, Bhubaneswar, Odisha, India., Rajasekhar L; Professor and Head, Department of Clinical Immunology and Rheumatology, Nizams Institute of Medical Science, Hyderabad, Telangana, India., Jain N; Senior Consultant and Vice-Chairman, Department of Rheumatology and Clinical Immunology, Sir Ganga Ram Hospital, New Delhi, Delhi, India., Nalawade A; Consultant Rheumatologist, Department of Rheumatology, Sancheti Hospital, Pune, India., Panchal S; Medical Advisor, Medical Affairs, Medical Affairs Delivery Unit, Asia Pacific, Johnson and Johnson Private Limited, Mumbai, Maharashtra, India, Corresponding Author., Shah N; Medical Advisor, Medical Affairs, Medical Affairs Delivery Unit, Asia Pacific, Johnson and Johnson Private Limited, Mumbai, Maharashtra, India., Korde T; Associate Director Global Trial Leader, Medical Affairs Delivery Unit, Asia Pacific, Johnson and Johnson Private Limited, Mumbai, Maharashtra, India., Dixit J; Director Evidence Generation Centre and Strategic Alliances, MAF RW Evidence, Janssen Inc., Ontario, Canada.
المصدر: The Journal of the Association of Physicians of India [J Assoc Physicians India] 2024 Mar; Vol. 72 (3), pp. 40-46.
نوع المنشور: Journal Article; Multicenter Study; Clinical Trial, Phase IV
بيانات الدورية: Publisher: Association of Physicians of India Country of Publication: India NLM ID: 7505585 Publication Model: Print Cited Medium: Print ISSN: 0004-5772 (Print) Linking ISSN: 00045772 NLM ISO Abbreviation: J Assoc Physicians India Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal*/therapeutic use , Antibodies, Monoclonal*/adverse effects , Antibodies, Monoclonal*/administration & dosage , Arthritis, Psoriatic*/drug therapy , Spondylitis, Ankylosing*/drug therapy, Humans ; Adult ; Male ; Female ; India ; Prospective Studies ; Middle Aged ; Treatment Outcome ; Injections, Subcutaneous ; Antirheumatic Agents/therapeutic use ; Antirheumatic Agents/administration & dosage ; Antirheumatic Agents/adverse effects